Collegium Pharmaceutical, Inc. Common Stock (COLL) Stock Price

COLLStock
$25.3533.90%52W
Market Cap$785.83M
P/E14.51x
PEG Ratio1.21
Div yield
Beta0.72

COLL Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-55.81%
Price vs S&P 500 (4W)-30.29%
PEG Ratio1.21
VGM Score56.76
P/E Ratio (Annual)14.51x

COLL Earnings Surprise History

QuarterReport dateEPS estimateEPS actualSurprise
Q2 2026$1.76$1.92+8.78%(+$0.16)
Q1 2026$1.52$1.76+15.52%(+$0.24)
Q4 2025$2.14$2.04-4.66%(-$0.10)
Q3 2025$1.86$2.25+20.97%(+$0.39)
Q2 2025$1.85$1.68-9.19%(-$0.17)

COLL Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.08
4.08
4.08
4.08

Industry Peers — Pharmaceuticals(570)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
COLLCollegium Pharmaceutical, Inc. Common Stock
BBD$25.35
LLYEli Lilly & Co.DBC$1174.61
JNJJohnson & JohnsonDCB$268.04
ABBVABBVIE INC.DCB$255.48
MRKMerck & Co., Inc.DCB$148.35
NVSNovartis AGCCC$153.81
AZNAstraZeneca PLCCBC$162.70
NVONovo-Nordisk A/SBCC$45.61
ABTAbbott LaboratoriesCCC$112.47
PFEPfizer Inc.CDB$27.96
VRTXVertex Pharmaceuticals IncDCB$541.69

About Collegium Pharmaceutical, Inc. Common Stock

Collegium Pharmaceutical is a biopharmaceutical company that develops and commercializes treatments for ADHD and moderate to severe pain in the United States. Its marketed product portfolio includes Jornay PM for ADHD, Belbuca and Xtampza ER for pain management, the Nucynta line (Nucynta ER and IR), and Symproic.